Biospecimen DonationNCT06781424
University of Central Florida BEEAST
An observational study of Biospecimen Donation and Environmental Impact, run by University of Central Florida at 1 site in United States.
Trial summary
Since the inception of aerospace travel, NASA has been collecting biospecimens from professional astronauts for research. With the recent growth of civilian aerospace travelers, there is a need for biospecimen banking for civilian astronauts. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Biospecimen Donation, Environmental Impact
- How many people
- 10,000 participants
- Where
- 1 siteUnited States
- Study dates
- 13 Jan 2025to 13 Jan 2075
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: The target population comprises of persons from many countries. Therefore, enrollees can be from other countries. However, biospecimen collection will occur in the USA.
Who may be able to join
- Primary Enrollees: adults, ages 18 and older, and persons who travel (such as space travel) or live in extreme environments (such as Antarctica).
- Secondary Enrollees: Referred adult family members (such as siblings and spouses) of primary enrollees.
- Tertiary Enrollees: Adult persons from the general public can enroll to serve as matching controls. Tertiary enrollees will be screened based on age, gender, race and ethnicity, country of residence, disease/ conditions and employment history.
- Pregnant women may choose to enroll.
Who cannot join
- adults unable to consent,
- minors (under age 18)
- prisoners
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
University of Central Florida
Orlando, Florida, 32827
Britney-Ann Wray, BS, CTBS, CCRP, 4072668742, britney-ann.wray@ucf.edu
Amoy Fraser, PhD, CCRP, PMP, 4072668742, amoy.fraser@ucf.edu
About this study
Official title: University of Central Florida Biobank for Extreme Environments, Aviation and Space Travel
Since the inception of aerospace travel, NASA has been collecting biospecimens from professional astronauts for research. With the recent growth of civilian aerospace travelers, there is a need for biospecimen banking for civilian astronauts. This protocol addresses this gap by being a biobank for civilian astronauts, their family members (to be controls) and others who are also doing travel to extreme environments (pilots, submariners).
Read the detailed description
The objective of the University of Central Florida College of Medicine's Biobank for Extreme Environments, Aviation and Space Travel (BEEAST) is to acquire, store, and distribute identifiable human biospecimens and health information for medical research purposes only. The target population are astronauts, aviators, submariners, persons living in extreme environments (such as Antarctica), and their families, and people from the general population who can serve as matching controls.
- Conditions
- Biospecimen Donation, Environmental Impact
- Keywords
- donate, biobank, biospecimen, astronaut, pilot
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Primary Partcipant | Participants who have who travel (such as space travel) or live in extreme environments (such as Antarctica). | |
| Secondary Participant | Participants who have been referred adult family members (such as siblings and spouses) of primary enrollees. | |
| Tertiary Partcipant | Participants from the general public to serve as matching controls. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Receipt of donated biospecimen for aerospace research
Donated biospecimens from participants will aid in the improvement of medical aerospace research. The key research divisions are cancer, cardiovascular, immunity and pathogenesis, neuroscience, and molecular microbiology.
Measured: 50 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Jan 2025
- Study start13 Jan 2025
- Primary completion13 Jan 2075 (estimated)
- Study completion13 Jan 2075 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Biospecimen DonationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Other
- Enrolment
- 10,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Central Florida
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06781424
- Sponsor's protocol ID
- STUDY00007332
- Status last verified
- Mar 2025
- First submitted
- 13 Jan 2025
- Last updated
- 26 Mar 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 26 Mar 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- University of Central Florida Biobank for Extreme Environments, Aviation and Space Travel
- ClinicalTrials.gov ID
- NCT06781424
- Acronym / sponsor ID
- STUDY00007332
- Conditions
- Biospecimen Donation, Environmental Impact
- Keywords
- donate, biobank, biospecimen, astronaut, pilot
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 10,000 participants (estimated)
- Lead sponsor
- University of Central FloridaUniversity, hospital or other
- Study start
- 13 Jan 2025 (actual)
- Primary completion
- 13 Jan 2075 (estimated)
- Study completion
- 13 Jan 2075 (estimated)
- First posted
- 17 Jan 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Since the inception of aerospace travel, NASA has been collecting biospecimens from professional astronauts for research. With the recent growth of civilian aerospace travelers, there is a need for biospecimen banking for civilian astronauts. This protocol addresses this gap by being a biobank for civilian astronauts, their family members (to be controls) and others who are also doing travel to extreme environments (pilots, submariners).
Detailed description
The objective of the University of Central Florida College of Medicine's Biobank for Extreme Environments, Aviation and Space Travel (BEEAST) is to acquire, store, and distribute identifiable human biospecimens and health information for medical research purposes only. The target population are astronauts, aviators, submariners, persons living in extreme environments (such as Antarctica), and their families, and people from the general population who can serve as matching controls.
Study design
- Observational model
- Other
- Time perspective
- Other
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Primary Partcipant | – | –Participants who have who travel (such as space travel) or live in extreme environments (such as Antarctica). |
| Secondary Participant | – | –Participants who have been referred adult family members (such as siblings and spouses) of primary enrollees. |
| Tertiary Partcipant | – | –Participants from the general public to serve as matching controls. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- The target population comprises of persons from many countries. Therefore, enrollees can be from other countries. However, biospecimen collection will occur in the USA.
Key inclusion criteria (4 listed)
- Primary Enrollees: adults, ages 18 and older, and persons who travel (such as space travel) or live in extreme environments (such as Antarctica).
- Secondary Enrollees: Referred adult family members (such as siblings and spouses) of primary enrollees.
- Tertiary Enrollees: Adult persons from the general public can enroll to serve as matching controls. Tertiary enrollees will be screened based on age, gender, race and ethnicity, country of residence, disease/ conditions and employment history.
- Pregnant women may choose to enroll.
Key exclusion criteria (3 listed)
- adults unable to consent,
- minors (under age 18)
- prisoners
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Receipt of donated biospecimen for aerospace research
Time frame: 50 years
Donated biospecimens from participants will aid in the improvement of medical aerospace research. The key research divisions are cancer, cardiovascular, immunity and pathogenesis, neuroscience, and molecular microbiology.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Mar 2025.
Related trials for Biospecimen Donation
Enrolling by invitationObservational study
Blood Donation Study for ALPCO Syphilis-T and Syphilis-NT Assay Development
Healthy Volunteers, Syphilis Serologic Assay Development
RecruitingObservational study
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
Anal Carcinoma, Hematopoietic and Lymphoid Cell Neoplasm
RecruitingObservational study
University of Central Florida CereBank
Biospecimen Donation, Brain Injury
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Biospecimen Donation and Environmental Impact, run by University of Central Florida at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 26 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Britney-Ann Wray, BS, CTBS, CCRP (4072668742, britney-ann.wray@ucf.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Receipt of donated biospecimen for aerospace research (time frame: 50 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Mar 2025.